Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Inhaled tPA for Pediatric Plastic Bronchitis
NCT02315898Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Mar 2018
- Primary completion
- Mar 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in plastic bronchitis (PB), sponsored by University of Michigan. Started Mar 2018; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
plastic bronchitis (PB)
Beyond the preview
Go deeper on NCT02315898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315898.